Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF152 (RNF152)

Target
RNF152
Molecular classification
Enzyme, E3 ubiquitin ligase, RING finger protein, Transmembrane protein
01

Overview

E3 ubiquitin-protein ligase RNF152 (RNF152) is a small, lysosome-localized, single-pass transmembrane RING finger protein with E3 ubiquitin ligase activity[1][2][3][6]. RNF152 is best known for its role as a negative regulator of the mTORC1 signaling pathway: under conditions such as amino acid starvation or absence of growth factors, it ubiquitinates small GTPases (e.g., RagA via K63-linked polyubiquitination, Rheb via monoubiquitination), thereby inhibiting mTORC1 activity and regulating cell growth and proliferation[3][6]. RNF152 also self-ubiquitinates, which regulates its own degradation[2]. Beyond mTORC1 regulation, RNF152 can suppress Wnt/β-catenin signaling and modulate inflammatory and developmental pathways, including neural crest formation and innate immune signaling—actions that can be dependent or independent of its enzymatic ligase activity[2]. Overexpression promotes apoptosis, making RNF152 functionally relevant to cell death, cancer, and possibly neurodegeneration[1][3]. It is associated with diseases including cancer, neurodegenerative diseases, and developmental disorders[3][5]. The identification and targeting of RNF152 is of growing interest for therapies modulating mTORC1- or Wnt-dependent pathologies.

Other names
Ring finger protein 152RING finger protein 152RING-type E3 ubiquitin transferase RNF152FLJ39176
02

Mechanism of action

Negative regulation of mTORC1 activity through ubiquitination of GDP-bound RagA (via K63 linkage) and GDP-bound Rheb (monoubiquitination), leading to inhibition of mTORC1 signaling[3][6] - Negative regulation of Wnt/β-catenin pathway by inhibiting Dishevelled polymerization (in some contexts, independent of ligase activity)[2] - Modulation of inflammatory signaling by facilitating MyD88 oligomerization (E3 activity-independent)[2]

03

Biological functions

Negative regulation of mTORC1 signalingUbiquitination of small GTPases (RagA, Rheb, possibly TSC2)Regulation of cellular response to amino acid starvationProtein ubiquitination (including auto-ubiquitination)Apoptosis inductionNegative regulation of Wnt/β-catenin signalingRegulation of neural crest formationModulation of inflammatory signaling (TLR/IL-1R pathway)
04

Disease associations

CancerNeurodegenerative diseaseImmunological/inflammatory diseaseDevelopmental disorders (e.g., defects in neural crest, pigmentation, craniofacial structures in animal models)
05

Safety considerations

Potential pro-apoptotic effects with overexpression[1]Broad impact on diverse signaling pathways (mTOR, Wnt/β-catenin, immune) may complicate therapeutic targetingRole in essential developmental and homeostatic processes
06

Interacting drugs

CB3A (experimental mTORC1 inhibitor; modulates RNF152-mediated ubiquitination in preclinical research)[6]
07

Biomarkers

mTORC1 activity (e.g., phosphorylation status of mTORC1 targets, RagA/Rheb ubiquitination)[3][6]Possibly neural crest markers or inflammatory signaling markers in research contexts[2]

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF152 (RNF152).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF152 (RNF152).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call